• Due to its mechanism of action and various anti-inflammatory effects, azithromycin is a promising medicine for the treatment of the coronavirus COVID-19. • The studies that have been done so far on the use of azithromycin in the management of the COVID-19 coronavirus have had various methodological limitations. At the moment, no conclusions can be drawn about the efficacy of this drug as an adjunct to hydroxychloroquine. • Azithromycin has serious cardiac adverse effects such as QT prolongation. Hydroxychloroquine also has them. The combination of these two drugs should be determined with caution. • At the moment 21 clinical trials are being carried out on the use of azithromycin in COVID-19.